Temofan 100 Capsule: Temozolomide 100 mg - Specialized Neuro-Oncology Care

Mechanism of Action: BBB-Penetrating Alkylating Agent for Brain Tumors

Key Indication: Concurrent and Adjuvant Therapy for Newly Diagnosed Glioblastoma (GBM)

Dosage Form Advantage: Capsule for Accurate, Discreet Oral Dosing in Long-Term Management

Important: Dosing Schedule and Monitoring for Myelosuppression
Secure Your Monopoly: Temofan 100 PCD Pharma Franchise in High-Value Neuro-Oncology

Temofan 100 Capsule

Composition : Temozolomide IP 100 mg Capsule

Dosage Form : Capsule

Packaging Type : in a Bottle

Packaging : 5 Capsule

Price : ₹0/-

Please Contact For Best Price

Temofan 100 Capsule (Temozolomide IP ) is a highly specialized, oral cytotoxic chemotherapy drug classified as an Alkylating Agent. It is the standard treatment backbone for patients diagnosed with the aggressive primary brain tumor, Glioblastoma Multiforme ().

Mechanism and Impact:Temozolomide rapidly converts to its active metabolite, MTIC, which is crucial because it can effectively cross the Blood-Brain Barrier () to target tumor cells in the central nervous system. MTIC causes DNA damage that triggers cell death. The Capsule form is the standard and preferred way to deliver this life-saving drug to patients at home during the long-term adjuvant phase.

Key Therapeutic Uses:

  • : Used concurrently with radiation therapy and subsequently as adjuvant monotherapy.

  • Anaplastic Astrocytoma: Used for patients who have relapsed or progressed.

Due to its high specialization and critical role in treating brain cancer, Temozolomide commands a premium market segment. We offer an exclusive PCD Pharma Franchise opportunity for Temofan 100 Capsule, ensuring partners access a high-value, niche neuro-oncology market with a trusted dosage form.

Read More

About the Product

Temofan 100 Capsule (Temozolomide IP ) is a highly specialized, oral cytotoxic chemotherapy drug classified as an Alkylating Agent. It is the standard treatment backbone for patients diagnosed with the aggressive primary brain tumor, Glioblastoma Multiforme ().

Mechanism and Impact:Temozolomide rapidly converts to its active metabolite, MTIC, which is crucial because it can effectively cross the Blood-Brain Barrier () to target tumor cells in the central nervous system. MTIC causes DNA damage that triggers cell death. The Capsule form is the standard and preferred way to deliver this life-saving drug to patients at home during the long-term adjuvant phase.

Key Therapeutic Uses:

  • : Used concurrently with radiation therapy and subsequently as adjuvant monotherapy.

  • Anaplastic Astrocytoma: Used for patients who have relapsed or progressed.

Due to its high specialization and critical role in treating brain cancer, Temozolomide commands a premium market segment. We offer an exclusive PCD Pharma Franchise opportunity for Temofan 100 Capsule, ensuring partners access a high-value, niche neuro-oncology market with a trusted dosage form.

Possible side effects include stomach upset, nausea, dizziness, or diarrhea. Rarely, allergic reactions or gastrointestinal bleeding may occur.

Mefasil Suspension is indicated for the relief of mild to moderate pain and inflammation, including headaches, menstrual pain, and musculoskeletal pain.

Use this medication as prescribed by your doctor. Avoid exceeding the recommended dosage. Inform your doctor of any existing medical conditions or ongoing medications.

Store the suspension in a cool, dry place, away from direct sunlight. Shake well before use. Keep out of reach of children.

Get in Touch